Correlation Between Eyenovia and Tenaya Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Tenaya Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Tenaya Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Tenaya Therapeutics, you can compare the effects of market volatilities on Eyenovia and Tenaya Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Tenaya Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Tenaya Therapeutics.

Diversification Opportunities for Eyenovia and Tenaya Therapeutics

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Eyenovia and Tenaya is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Tenaya Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenaya Therapeutics and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Tenaya Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenaya Therapeutics has no effect on the direction of Eyenovia i.e., Eyenovia and Tenaya Therapeutics go up and down completely randomly.

Pair Corralation between Eyenovia and Tenaya Therapeutics

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Tenaya Therapeutics. In addition to that, Eyenovia is 2.03 times more volatile than Tenaya Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. Tenaya Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest  187.00  in Tenaya Therapeutics on August 24, 2024 and sell it today you would earn a total of  29.00  from holding Tenaya Therapeutics or generate 15.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Tenaya Therapeutics

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Tenaya Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tenaya Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Eyenovia and Tenaya Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Tenaya Therapeutics

The main advantage of trading using opposite Eyenovia and Tenaya Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Tenaya Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenaya Therapeutics will offset losses from the drop in Tenaya Therapeutics' long position.
The idea behind Eyenovia and Tenaya Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets